Search

Background and Aim Non-alcoholic fatty liver disease is a type of accumulation of fat in the liver cells. Moreover, portulaca oleracea has hypolipidemic properties. Accordingly, the present study aimed to investigate the effect of a combination of training and portulaca oleracea supplementation on plasma lipid profile and liver ultrasound in obese women with nonalcoholic fatty liver. Methods & Materials The study population consisted of 40 to 60-year-old obese women with non-alcoholic fatty liver disease. In total, 40 obese women with nonalcoholic fatty liver disease were randomly selected and divided into 4 groups. The study groups included training (n=10), training + supplementation (n=10), placebo (n=10) and supplementation (n=10). Before and after the intervention, sonography of the liver and blood tests were performed. The Paired Samples t-test and Analysis of Variance (ANOVA) were used to analyze the obtained data. The significance level was set at P<0.05. Ethical Considerations This study was approved by the Research Ethics Committee of Islamic Azad University, Rasht Branch, Iran (code: IR. IAU.RASHT.REC. 1397. 034). Moreover, it was registered at the Iranian Registry of Clinical Trials (IRCT) (code: IRCT201903090429871). Results The obtained data suggested that 12 weeks of portulaca oleracea supplementation and combination training significantly decreased the plasma concentrations of cholesterol (P=0.001), triglyceride (P=0.00), LDL (P=0.00), and significantly increased serum HDL levels (P=0.00) in the exercise + supplement, supplement, and exercise groups (P<0.05). Liver ultrasound data also improved in the exercise + supplement (P=0.02), and exercise (P=0.00) groups. Conclusion Portulaca oleracea supplementation with combination exercises could be effective in reducing plasma lipids and improving liver ultrasound in obese women with nonalcoholic fatty liver. [ABSTRACT FROM AUTHOR]

Background: Considering the high prevalence of diabetes and developing cardiovascular diseases through dyslipidemia and inflammation in type 2 diabetic patients, the aim of the present study was to investigate the effects of oligofructose-enriched inulin on serum lipid concentrations and inflammation in women with type 2 diabetes. Materials and Methods: In this clinical trial, 52 women with type 2 diabetes were randomly assigned to one of two groups. Experimental group (n=27) received 10g/day oligofructose-enriched inulin and control group (n=25) received 10g/day maltodextrin (placebo) for 8 weeks. Dietary intakes, anthropometric indicies, hs-CRP and serum lipids levels were measured at the baseline and at the end of the study. Data were analyzed using SPSS software (verision11.5). Paired, independent t-test and ANCOVA were used to compare comparison of quantitative variables. Results: At the end of study, significant decrease was observed in total cholesterol levels mean (28.00 mg/dL, 14.10%), LDL-c (22.00 mg/dL, 21.70%), TC/HDL-c ratio (0.73, 20.70%) and LDL-c/HDL-c ratio (0.55, 27.50%) in oligofructose-enriched inulin compared with the maltodextrin group (p=0.03). Changes in concentrations of triglycerides, hsCRP and high-density lipoprotein were not significant in oligofructose-enriched inulin compared to maltodextrin group. Conclusions: Oligofructose-enriched inulin supplementation with improving in inflammtion and lipid profile help in management of type 2 diabetes and its complications. [ABSTRACT FROM AUTHOR]